Ahsan Ragib, Kifayat Sumaiya, Pooniya Krishan Kumar, Kularia Sunita, Adimalla Bhavani Sailu, Sanapalli Bharat Kumar Reddy, Sanapalli Vidyasrilekha, Sigalapalli Dilep Kumar
Department of Pharmacy, NIMS Institute of Pharmacy, NIMS University, Jaipur 303121, Rajasthan, India.
Department of Pharmacology, NIMS Institute of Pharmacy, NIMS University, Jaipur 303121, Rajasthan, India.
Antibiotics (Basel). 2024 Jun 22;13(7):576. doi: 10.3390/antibiotics13070576.
Bacterial histidine kinase (BHK) is a constituent of the two-component signaling (TCS) pathway, which is responsible for the regulation of a number of processes connected to bacterial pathogenicity, virulence, biofilm development, antibiotic resistance, and bacterial persistence. As BHK regulation is diverse, inhibitors can be developed, such as antibiotic synergists, bacteriostatic/bactericidal agents, virulence inhibitors, and biofilm inhibitors. Inhibition of essential BHK has always been an amenable strategy due to the conserved binding sites of the domains across bacterial species and growth dependence. Hence, an inhibitor of BHK might block multiple TCS regulatory networks. This review describes the TCS system and the role of BHK in bacterial virulence and discusses the available inhibitors of BHK, which is a specific response regulator with essential structural features.
细菌组氨酸激酶(BHK)是双组分信号传导(TCS)途径的一个组成部分,该途径负责调节许多与细菌致病性、毒力、生物膜形成、抗生素耐药性和细菌持续性相关的过程。由于BHK的调节作用多种多样,因此可以开发抑制剂,如抗生素增效剂、抑菌/杀菌药物、毒力抑制剂和生物膜抑制剂。由于跨细菌物种的结构域具有保守的结合位点以及生长依赖性,抑制必需的BHK一直是一种可行的策略。因此,BHK抑制剂可能会阻断多个TCS调节网络。本综述描述了TCS系统以及BHK在细菌毒力中的作用,并讨论了现有的BHK抑制剂,BHK是一种具有重要结构特征的特异性应答调节因子。